A promising new mRNA-based vaccine for pancreatic cancer has shown potential in reducing the recurrence of the disease post-surgery. MSK's phase 1 cli ...

The mRNA vaccine works by targeting genetic mutations found in pancreatic cancer, alerting the immune system to recognize and ...

The findings underscore the need for telehealth policies that can accommodate the needs of patients who cross state lines for cancer care, reported Tracy Onega, PhD, of the Univer ...

A Memorial Sloan Kettering phase 1 clinical trial revealed an immune response in some pancreatic cancer patients. Study ...

Kauvery Hospital Vadapalani, a leading healthcare institution renowned for its advanced surgical techniques, has performed a ...

A personalized mRNA vaccine may reduce the risks of pancreatic cancer returning after surgery, according to a preliminary ...

A clinical trial from Memorial Sloan Kettering Cancer Center looked at the effects of a targeted mRNA vaccine on early-stage ...

Toni Bravo thought she was having an anxiety attack a couple weeks before finals at the University of Notre Dame last year.

Due to a lack of noticeable symptoms in its early stages and the pancreas’ obscure location behind other organs in the ...

However, some nerve fibers remained active and continued promoting cancer growth. To completely cut off nerve support, the ...

When stage 4 pancreatic cancer progresses through metastasis to abdominal organs and potentially spreads to distant sites ...